Mylan Pharmaceuticals Inc. recalls Amlodipine and Benazapril HCL Capsules, USP, 5 mg/10 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV

Recalled May 23, 2018 · FDA recall D-0819-2018 · Mylan Pharmaceuticals

Hazard

cGMP Deviations; cleaning process for equipment used to manufacture the specified batches was not followed according to procedure · FDA Class II

Units

25,488 bottles

Sold at

Product was distributed throughout United States

Description

cGMP Deviations; cleaning process for equipment used to manufacture the specified batches was not followed according to procedure

Product

Amlodipine and Benazapril HCL Capsules, USP, 5 mg/10 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-6896-01

Manufacturer(s)

Mylan Pharmaceuticals Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →